Lisbet Brandi

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, University of Copenhagen, Denmark
    Nephrol Dial Transplant 17:829-42. 2002
  2. ncbi Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    Nephron Clin Pract 99:c128-37. 2005
  3. ncbi 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, Copenhagen, Denmark
    Dan Med Bull 55:186-210. 2008

Detail Information

Publications3

  1. ncbi Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, University of Copenhagen, Denmark
    Nephrol Dial Transplant 17:829-42. 2002
    ..The aim of the present study was to evaluate the pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) after oral and i.v. administration in healthy volunteers and uraemic patients...
  2. ncbi Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    Nephron Clin Pract 99:c128-37. 2005
    ....
  3. ncbi 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis
    Lisbet Brandi
    Nephrological Department P, Rigshospitalet, Copenhagen, Denmark
    Dan Med Bull 55:186-210. 2008
    ..There is an urgent need for a development of an algorithm for the use of phosphate binders and vitamin D supplementation in combination with calcimimetics focusing upon long term morbidity and mortality in uremic patients...